Quantitative proteomics analysis by isobaric tags for relative and absolute quantitation identified Lumican as a potential marker for acute aortic dissection

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Gu, Guorong ^a   Cheng, Weizhong ^a   Yao, Chenling ^a   Yin, Jun ^a   Tong, Chaoyang ^a   Rao, Andrew ^b   Yen, Lawrence ^b   Ku, Matthew ^b   Rao, Jianyu ^b  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CERULOPLASMIN; FIBRONECTIN; HAPTOGLOBIN; LUMICAN; MYOGLOBIN; TROPONIN T; BIOLOGICAL MARKER; KERATAN SULFATE; PROTEOCHONDROITIN SULFATE; PROTEOME;

ACUTE AORTIC DISSECTION; ACUTE HEART INFARCTION; ADULT; AGED; AMINO ACID SEQUENCE; AORTA DISSECTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; ISOBARIC TAG FOR RELATIVE AND ABSOLUTE QUANTITATION; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEOMICS; UNINDEXED SEQUENCE; AORTA ANEURYSM; BLOOD; CASE CONTROL STUDY; CLASSIFICATION; DISSECTING ANEURYSM; HEART INFARCTION; HOSPITALIZATION; ISOTOPE LABELING; METHODOLOGY; MIDDLE AGED; TIME;

ANEURYSM, DISSECTING; AORTIC ANEURYSM; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHONDROITIN SULFATE PROTEOGLYCANS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZATION; HUMANS; ISOTOPE LABELING; KERATAN SULFATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROTEOME; PROTEOMICS; TIME FACTORS;

EID: 84855521828     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/920763     Document Type: Article

References (28)

1. Elefteriades J. A., Barrett P. W., Kopf G. S., Litigation in nontraumatic aortic diseases: a tempest in the malpractice maelstrom Cardiology 2008 109 4 263 272 (Pubitemid 351328922)
2. Suzuki T., Distante A., Eagle K., Biomarker-assisted diagnosis of acute aortic dissection: how far we have come and what to expect Current Opinion in Cardiology 2010 25 6 541 545
3. Shinohara T., Suzuki K., Okada M., Shiigai M., Shimizu M., Maehara T., Ohsuzu F., Soluble elastin fragments in serum are elevated in acute aortic dissection Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 10 1839 1844 (Pubitemid 37254872)
4. Boylan K. L. M., Andersen J. D., Anderson L. B., Higgins L., Skubitz A. P. N., Quantitative proteomic analysis by iTRAQ for the identification of candidate biomarkers in ovarian cancer serum Proteome Science 2010 8, article 31
5. Latterich M., Abramovitz M., Leyland-Jones B., Proteomics: new technologies and clinical applications European Journal of Cancer 2008 44 18 2737 2741
6. Song X., Bandow J., Sherman J., David Baker J., Brown P. W., McDowell M. T., Molloy M. P., iTRAQ experimental design for plasma biomarker discovery Journal of Proteome Research 2008 7 7 2952 2958
7. Kolla V., Jen P., Moes S., Tercanli S., Lapaire O., Choolani M., Hahn S., Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ) Journal of Biomedicine Biotechnology 2010 2010 10
8. Chee S. G., Poh K. C., Trong K. P., Wright P. C., Technical, experimental, and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ) Journal of Proteome Research 2007 6 2 821 827 (Pubitemid 46340185)
9. Magharious M., D'Onofrio P. M., Hollander A., Zhu P., Chen J., Koeberle P. D., Quantitative iTRAQ analysis of retinal ganglion cell degeneration after optic nerve crush Journal of Proteome Research 2011 10 8 3344 3362
10. Zhang Z., Zhang L., Hua Y., Jia X., Li J., Hu S., Peng X., Yang P., Sun M., Ma F., Cai Z., Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines BMC Cancer 2010 10, article 206
11. Trimarchi S., Sangiorgi G., Sang X., Rampoldi V., Suzuki T., Eagle K. A., Elefteriades J. A., In search of blood tests for thoracic aortic diseases Annals of Thoracic Surgery 2010 90 5 1735 1742
12. Domanovits H., Schillinger M., Mllner M., Hlzenbein T., Janata K., Bayegan K., Laggner A. N., Acute phase reactants in patients with abdominal aortic aneurysm Atherosclerosis 2002 163 2 297 302 (Pubitemid 34615820)
13. Sakakura K., Kubo N., Ako J., Wada H., Fujiwara N., Funayama H., Ikeda N., Nakamura T., Sugawara Y., Yasu T., Kawakami M., Momomura S. I., Peak C-reactive protein level predicts long-term outcomes in type B acute aortic dissection Hypertension 2010 55 2 422 429
14. Makita S., Ohira A., Tachieda R., Itoh S., Moriai Y., Yoshioka K., Niinuma H., Nakamura M., Hiramori K., Behavior of C-reactive protein levels in medically treated aortic dissection and intramural hematoma American Journal of Cardiology 2000 86 2 242 244 (Pubitemid 30410742)
15. Yasojima K., Schwab C., McGeer E. G., McGeer P. L., Generation of C-reactive protein and complement components in atherosclerotic plaques American Journal of Pathology 2001 158 3 1039 1051 (Pubitemid 32221796)
16. Celik T., Iyisoy A., Kursaklioglu H., Turhan H., Isik E., Does the pre-existing inflammation play a role in the increased C-reactive protein levels in acute myocardial infarction? International Journal of Cardiology 2006 112 1 134 135 (Pubitemid 44247190)
17. Vandercappellen J., Van Damme J., Struyf S., The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer Cytokine and Growth Factor 2011 22 1 1 18
18. Blair P., Flaumenhaft R., Platelet -granules: basic biology and clinical correlates Blood Reviews 2009 23 4 177 189
19. Struyf S., Burdick M. D., Proost P., Van Damme J., Stricter R. M., Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis Circulation Research 2004 95 9 855 857 (Pubitemid 39434999)
20. Shi G., Morrell C. N., Platelets as initiators and mediators of inflammation at the vessel wall Thrombosis Research 2011 127 5 387 390
21. Tanaka M., Kawahito K., Adachi H., Ino T., Platelet dysfunction in acute type A aortic dissection evaluated by the laser light-scattering method Journal of Thoracic and Cardiovascular Surgery 2003 126 3 837 841 (Pubitemid 37151973)
22. Romberger D. J., Fibronectin The International Journal of Biochemistry Cell Biology 1997 29 7 939 934
23. Peters J. H., Grote M. N., Lane N. E., Maunder R. J., Changes in plasma fibronectin isoform levels predict distinct clinical outcomes in critically III patients Biomarker Insights 2011 6 59 68
24. Lucena S., Arocha Piango C. L., Guerrero B., Fibronectin. Structure and functions associated to hemostasis. Review Investigacion Clinica 2007 48 2 249 262 (Pubitemid 47105459)
25. rem C., elik S. O., rem A., Calapolu M., Erdl C., Increased plasma fibronectin levels in patients with acute myocardial infarction complicated with left ventricular thrombus Thrombosis Research 2002 105 1 37 41 (Pubitemid 34178306)
26. Smadja D. M., D'Audigier C., Biche I., Evrard S., Mauge L., Dias J. -V., Labreuche J., Laurendeau I., Marsac B., Dizier B., Wagner-Ballon O., Boisson-Vidal C., Morandi V., Duong-Van-Huyen J. -P., Bruneval P., Dignat-George F., Emmerich J., Gaussem P., Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 3 551 559
27. Qin H., Ishiwata T., Asano G., Effects of the extracellular matrix on lumican expression in rat aortic smooth muscle cells in vitro Journal of Pathology 2001 195 5 604 608 (Pubitemid 34030799)
28. Naito Z., The role of small leucine-rich proteoglycan (SLRP) family in pathological lesions and cancer cell growth Journal of Nippon Medical School 2005 72 3 137 145 (Pubitemid 40943770)